Friday, February 29, 2008

Misconduct: Where are the Consequences?

›
A story on Bloomberg starts as follows: James C. Vestal, a Texas urologist, exposed his patients to ``unnecessary risk'' and ``subm...

Nominee for Career Achievement Award: Dr. David Linden

›
Remember him? The guy who gave herpes to two patients and lost his license for three months as a result (pretty stiff penalty, eh?). Accor...
2 comments:
Tuesday, February 26, 2008

Scientific Misconduct, Version 4309

›
According to the Center for Science in the Public Interest : A chemist in India plagiarized or falsified more than 70 research papers publis...

Antidepressants: Meet the New News, Same as the Old News

›
A recent meta-analysis from Irving Kirsch and colleagues (available here in PLoS Medicine ) indicated that for the great majority of depress...
2 comments:
Friday, February 22, 2008

Welfare Queens on Fiapta Demand Confidential Peer Reviews

›
I've been very neglectful in linking to a number of very interesting stories by my compadres in the blogging world. So here is a limite...
1 comment:
Thursday, February 21, 2008

American Psychological Association: A Wink and Nod Toward Torture?

›
I've monitored the issue of psychologist involvement in torture on and off for the last few years. Honestly, if I wasn't spending m...
Wednesday, February 20, 2008

Medical Bribery: We Want Details

›
When drug companies provide kickbacks and bribes to physicians, they sometimes make the news for a brief spin around the news cycle, followe...
2 comments:
Tuesday, February 19, 2008

Andorra Ain't In Africa?

›
Nation Of Andorra Not In Africa, Shocked U.S. State Dept. Reports
1 comment:

Why I Love the Discussion Section

›
A recent study in the Journal of Clinical Psychopharmacology found that aripiprazole (Abilify) offered no benefit over placebo in treating ...
2 comments:
Wednesday, February 13, 2008

Key Opinion Leaders and Information Laundering: The Case of Paxil

›
Joseph Glenmullen’s testimony regarding GlaxoSmithKline’s burial of suicide data related to Paxil, which was discussed briefly across the b...
1 comment:
Tuesday, February 12, 2008

Today's Teachers Tackle The Tough Issues

›
You'd think this was from The Onion , but no, it is from the latest edition of American Teacher , the official publication of the Americ...
2 comments:
Wednesday, February 06, 2008

Go To Furious Seasons

›
Philip Dawdy has written many interesting posts of late and I encourage everyone to read his blog religiously while I take some time to att...
Friday, February 01, 2008

Mood Stablizers and Suicide

›
As reported on Pharmalot and Furious Seasons , the antiepileptic/"mood stabilizer" class of drugs has been stuck with a suicide w...
2 comments:
Thursday, January 31, 2008

Peer Review, GSK, Cash, and Limp Noodles

›
Stephanie Saul has a quite interesting story in the New York Times about a peer-reviewer who really dropped the ball. A key member of th...
Tuesday, January 29, 2008

Fred Hassan's Hindquarters: Meet Peter Rost's Boot

›
Schering-Plough CEO Fred Hassan gets served (link contains adult language) by Peter Rost. Badly. While Hassan has been hailed as some sor...
1 comment:

The Serotonin Monster Strikes Again

›
Last Halloween, I discussed the legendary Serotonin Monster , that is, the alleged chemical imbalance that causes depression, anxiety, aggre...
1 comment:
Friday, January 25, 2008

Bribing Physicians: Where My Money At?

›
An utterly fascinating article in the Wall Street Journal by Vanessa Fuhrmans notes that insurers are moving to bribe doctors for prescribi...
3 comments:
Thursday, January 24, 2008

My Political Leanings Are Out in the Open (Sort of)

›
As noted on the Scientific Misconduct Blog and PharmaGossip , there is an online test available (the Political Compass ) that claims to mea...
1 comment:
Wednesday, January 23, 2008

Key Opinion Leaders, Continuing Medical Education, and Utter B.S.

›
Psychiatrist Bernard Carroll has another brilliant post on corrupt, er, continuing medical education (CME) and how the process has been co...
1 comment:
Tuesday, January 22, 2008

Defending the Hiding of Negative Clinical Trial Data

›
In the wake of the New England Journal of Medicine study that revealed a sizable discrepancy between the raw data on antidepressants and th...
4 comments: